Skip to Content
You are currently on the new version of our website. Access the old version .

Medical Sciences Forum, Volume 39, Issue 1

2025 IKCSEU 2025 - 4 articles

The 2025 International Kidney Cancer Symposium

Amsterdam, The Netherlands | 1–3 May 2025

Volume Editors:
Axel Bex, The Netherlands Cancer Institute, The Netherlands
Ignacio Durán, Hospital Universitario Marqués de Valdecilla, Spain
Salvatore La Rosa, Kidney Cancer Association, USA
Lisa Pickering, Royal Marsden Hospital, UK

Cover Story: The 2025 International Kidney Cancer Symposium—Europe (IKCSEU25) was held in Amsterdam, The Netherlands, on 1–3 May 2025, organized by the Kidney Cancer Association (KCA). This annual event serves as the premier European meeting dedicated to kidney cancer research and clinical innovation, fostering collaboration across academia, industry, and advocacy. The symposium showcased cutting-edge research in kidney cancer, highlighting advancements in tumor biology, translational science, real-world evidence, biomarkers, imaging, therapeutics, and quality of care. IKCSEU25 also featured interactive sessions such as Practice Changing Papers, The Woodfire, and Young Investigator Highlights, encouraging multidisciplinary dialogue and translational collaboration.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

  • Conference Report
  • Open Access
1,199 Views
44 Pages

Abstracts of the 2025 International Kidney Cancer Symposium (IKCS) Europe

  • Axel Bex,
  • Ignacio Durán,
  • Salvatore La Rosa and
  • Lisa Pickering

The 2025 International Kidney Cancer Symposium—Europe (IKCSEU25) was held in Amsterdam, the Netherlands, from 1 to 3 May 2025, organized by the Kidney Cancer Association (KCA). This annual event serves as the premier European meeting dedicated...

  • Proceeding Paper
  • Open Access
555 Views
5 Pages

The Importance of Multidisciplinary Team Meetings (MDMs) with Focus on Minimal Surgery

  • Lars Lund,
  • Else Helene Ibfelt,
  • Heidi Larsson,
  • Niels Fristrup,
  • Anne Kirstine Møller Darras and
  • Mette Nørgaard

Since 2010, all Danish departments treating renal cell carcinoma (RCC) have reported to the national quality database, enabling systematic auditing of outcomes. Using the unique Civil Registration Number, data are linked to national registries, ensur...

  • Proceeding Paper
  • Open Access
784 Views
10 Pages

First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer

  • Simon Nannini,
  • Fabien Moinard-Butot,
  • Sylvain Ladoire,
  • Dorian Bochaton,
  • Pierre Bigot,
  • Félix Lefort,
  • Hakim Mahammedi,
  • Fabien Calcagno,
  • Jean-Baptiste Barbe Richaud and
  • Philippe Barthélémy
  • + 5 authors

The CABONEXT study is the first multicenter retrospective analysis evaluating subsequent systemic therapies after cabozantinib-based treatment in metastatic renal cell carcinoma (mRCC). This interim analysis includes 77 patients receiving subsequent...

  • Proceeding Paper
  • Open Access
700 Views
5 Pages

Background: Artificial intelligence (AI) has the potential to significantly enhance clinical decision-making in oncology. However, its application in renal cell carcinoma (RCC) remains limited. The ART (Artificial Intelligence in Renal Tumors) projec...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Med. Sci. Forum - ISSN 2673-9992